Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial

OBJECTIVE: Previous studies have shown additive weight loss when intensive behavioral therapy (IBT) was combined with weight‐loss medication. The present multisite study provides the first evaluation, in primary care, of the effect of the Centers for Medicare and Medicaid Services–based IBT benefit,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadden, Thomas A., Tronieri, Jena Shaw, Sugimoto, Danny, Lund, Michael Taulo, Auerbach, Pernille, Jensen, Camilla, Rubino, Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065111/
https://www.ncbi.nlm.nih.gov/pubmed/32090517
http://dx.doi.org/10.1002/oby.22726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065111/
https://www.ncbi.nlm.nih.gov/pubmed/32090517
http://dx.doi.org/10.1002/oby.22726

Ejemplares similares